These findings highlight the association between HER+ tumor niches with more aggressive clinical features (i.e., higher grade and HER2+ subtype) and the association between CKhighCXCL12high tumor niches and less aggressive features (i.e., lower grade and HR+/HER2− subtype). The gene discussed is ERBB2; the disease is neoplasm.